Alembic gets USFDA nod to market generic drug

The company has received tentative approval from the US Food Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for lvabradine tablets (5 mg and 7.5 mg), Alembic Pharmaceuticals said in a regulatory filing.

from Moneycontrol Business News https://ift.tt/1JeXbCf